Zobrazeno 1 - 10
of 3 577
pro vyhledávání: '"left ventricular outflow"'
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 19, Iss 1, Pp 1-4 (2024)
Abstract Background Left ventricular outflow tract stenosis and atrioventricular valve regurgitation are often problems encountered in adulthood after complete atrioventricular septal defect repair. The surgical approach and indications for managing
Externí odkaz:
https://doaj.org/article/2918cd1671b44f47a13872b78d202ba1
Autor:
Sameh M. Said
Publikováno v:
Kardiyovasküler Tıp E Dergisi/E Journal of Cardiovascular Medicine, Vol 12, Iss 3, Pp 68-76 (2024)
Hypertrophic cardiomyopathy is a prevalent cause of sudden cardiac death among young people. This distinctive genetic condition can manifest at any age from infancy to adulthood. The primary features include unexplained left ventricular hypertrophy c
Externí odkaz:
https://doaj.org/article/ff4b1ccf968b4a80a56abde573ce3170
Autor:
Rahul Mehrotra
Publikováno v:
Journal of the Indian Academy of Echocardiography & Cardiovascular Imaging, Vol 8, Iss 2, Pp 100-107 (2024)
Hypertrophic cardiomyopathy (HCM) is a common disorder characterized by unexplained left ventricular hypertrophy. The disease can have different phenotypic expressions and can be genetic in nature with autosomal dominant inheritance. It usually runs
Externí odkaz:
https://doaj.org/article/0993305a4c724103b3431b0794fbf4fd
Publikováno v:
Journal of the Practice of Cardiovascular Sciences, Vol 10, Iss 2, Pp 100-102 (2024)
Thrombus formation inside the left ventricle (LV) is a dreaded complication following myocardial infarction. Depending on their anatomical characteristics, they pose a significant risk of embolism, specifically stroke. Cardiac surgery in a patient wi
Externí odkaz:
https://doaj.org/article/9e1959b6a44446c6b65c5347ef98d604
Publikováno v:
International Medical Case Reports Journal, Vol Volume 17, Pp 719-723 (2024)
Qing Zhang, Yao Xu, Hao Wang, Xuelian Pang, Qingfeng Meng Department of Cardiology, Qilu Hospital of Shandong University, Qingdao, People’s Republic of ChinaCorrespondence: Xuelian Pang; Qingfeng Meng, Email pxl18561810097@163.com; mengfeng0912@163
Externí odkaz:
https://doaj.org/article/5706b9f4ae684d16869b0f0fe6025d95
Autor:
Victor N. Rivas, Amanda E. Crofton, Carina E. Jauregui, Jalena R. Wouters, Betty S. Yang, Luke A. Wittenburg, Joanna L. Kaplan, Darren T. Hwee, Anne N. Murphy, Bradley P. Morgan, Fady I. Malik, Samantha P. Harris, Joshua A. Stern
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Hypertrophic cardiomyopathy (HCM) remains the most common cardiomyopathy in humans and cats with few preclinical pharmacologic interventional studies. Small-molecule sarcomere inhibitors are promising novel therapeutics for the management of
Externí odkaz:
https://doaj.org/article/1940ab1525324fb69489f617ae0a6c84
Autor:
Kira Mascho, Svetlana A. Yatsenko, Cecilia W. Lo, Xinxiu Xu, Jennifer Johnson, Lindsey R. Helvaty, Stephanie Burns Wechsler, Chaya N. Murali, Seema R. Lalani, Vidu Garg, Jennelle C. Hodge, Kim L. McBride, Stephanie M. Ware, Jiuann-Huey Ivy Lin
Publikováno v:
Frontiers in Genetics, Vol 15 (2024)
Introduction5p deletion syndrome, also called Cri-du-chat syndrome 5p is a rare genetic syndrome with reports up to 36% of patients are associated with congenital heart defects. We investigated the association between left outflow tract obstruction a
Externí odkaz:
https://doaj.org/article/2ea28b86dde34d79982956d3247450a9
Autor:
Carolina Espejo‐Paeres, Luis Alfonso Marroquín‐Donday, Breda Hennessey, Lin Wang, Angela McInerney, José G. Paredes‐Vázquez, María Pérez‐Vizcayno, Gabriela Tirado‐Conte, Fernando Macaya‐Ten, Hernán Mejía‐Rentería, Pablo Salinas, Iván Javier Núñez‐Gil, Nieves Gonzalo, Luis Nombela‐Franco, Javier Escaned, Antonio Fernández‐Ortiz, Julián Pérez‐Villacastín, Pilar Jiménez‐Quevedo
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 19 (2024)
Background Conduction disturbances represent one of the most common complications following transcatheter aortic valve replacement (TAVR). We sought to investigate the role of left ventricular outflow tract (LVOT) morphology in the development of con
Externí odkaz:
https://doaj.org/article/0a992a2afb344ef694d4eedfa8406fc1
Autor:
Karin Del Vecchio, Caterina Rizzardi, Alice Pozza, Francesco Prati, Luisa Ye, Alessia Fattoretto, Elena Reffo, Giovanni Di Salvo
Publikováno v:
Monaldi Archives for Chest Disease (2024)
Pediatric hypertrophic cardiomyopathy (HCM) has a wide range of clinical manifestations. Left ventricular outflow tract obstruction (LVOTO) at rest is present in up to one-third of children with HCM, with a further 50-60% of symptomatic children deve
Externí odkaz:
https://doaj.org/article/d98f5a52b38a4b4297186eed4f232bff
Autor:
Anjali T. Owens, Milind Desai, Matthew T. Wheeler, Anna Rodonski, Samira Merali, Amy J. Sehnert, Sara Saberi
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 17 (2024)
Mavacamten is the first and only cardiac myosin inhibitor approved in 5 continents for the treatment of adults with symptomatic New York Heart Association class II and III obstructive hypertrophic cardiomyopathy. An evidence‐based rationale was use
Externí odkaz:
https://doaj.org/article/a01f4f2d76b64c1f85ec6c340522d7c9